{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:53:38Z","timestamp":1781520818294,"version":"3.54.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Invion Ltd"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Photochem Photobiol Sci"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s43630-026-00906-z","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T13:52:29Z","timestamp":1777297949000},"page":"1129-1143","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification and characterization of phyllochlorin sodium as a novel chlorin-derived photosensitiser"],"prefix":"10.1007","volume":"25","author":[{"given":"Yiqian","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4252-7633","authenticated-orcid":false,"given":"Sebastian M.","family":"Marcuccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Marcuccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honsue","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew N.","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"issue":"4","key":"906_CR1","first-page":"250","volume":"61","author":"P Agostinis","year":"2011","unstructured":"Agostinis, P., et al. (2011). Photodynamic therapy of cancer: an update. C Ca: A Cancer Journal For Clinicians, 61(4), 250\u2013281.","journal-title":"C Ca: A Cancer Journal For Clinicians"},{"issue":"9\u201310","key":"906_CR2","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s10495-020-01634-0","volume":"25","author":"D Kessel","year":"2020","unstructured":"Kessel, D. (2020). Photodynamic therapy: apoptosis, paraptosis and beyond. Apoptosis, 25(9\u201310), 611\u2013615.","journal-title":"Apoptosis"},{"issue":"7","key":"906_CR3","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrc1894","volume":"6","author":"AP Castano","year":"2006","unstructured":"Castano, A. P., Mroz, P., & Hamblin, M. R. (2006). Photodynamic therapy and anti-tumour immunity. Nature Reviews Cancer, 6(7), 535\u2013545.","journal-title":"Nature Reviews Cancer"},{"key":"906_CR4","doi-asserted-by":"publisher","first-page":"107221","DOI":"10.1016\/j.ejps.2025.107221","volume":"213","author":"T Le Clainche","year":"2025","unstructured":"Le Clainche, T., et al. (2025). Photodynamic drug delivery for cancer therapy: Designing liposomes for light-controlled release and enhanced drug efficacy. European Journal Of Pharmaceutical Sciences, 213, 107221.","journal-title":"European Journal Of Pharmaceutical Sciences"},{"issue":"4","key":"906_CR5","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1021\/cr5004198","volume":"115","author":"SS Lucky","year":"2015","unstructured":"Lucky, S. S., Soo, K. C., & Zhang, Y. (2015). Nanoparticles in photodynamic therapy. Chemical Reviews, 115(4), 1990\u20132042.","journal-title":"Chemical Reviews"},{"issue":"1","key":"906_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1572-1000(04)00007-9","volume":"1","author":"RR Allison","year":"2004","unstructured":"Allison, R. R., et al. (2004). Photosensitizers in clinical PDT. Photodiagnosis Photodyn Ther, 1(1), 27\u201342.","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"4","key":"906_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.pdpdt.2013.03.011","volume":"10","author":"RR Allison","year":"2013","unstructured":"Allison, R. R., & Moghissi, K. (2013). Oncologic photodynamic therapy: clinical strategies that modulate mechanisms of action. Photodiagnosis Photodyn Ther, 10(4), 331\u2013341.","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"5","key":"906_CR8","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/jdv.12031","volume":"27","author":"CA Morton","year":"2013","unstructured":"Morton, C. A., et al. (2013). European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen\u2019s disease, basal cell carcinoma. Journal Of The European Academy Of Dermatology And Venereology, 27(5), 536\u2013544.","journal-title":"Journal Of The European Academy Of Dermatology And Venereology"},{"issue":"9","key":"906_CR9","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1111\/jdv.12974","volume":"29","author":"CA Morton","year":"2015","unstructured":"Morton, C. A., et al. (2015). Practical approach to the use of daylight photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: a European consensus. Journal Of The European Academy Of Dermatology And Venereology, 29(9), 1718\u20131723.","journal-title":"Journal Of The European Academy Of Dermatology And Venereology"},{"issue":"1","key":"906_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0169-5002(03)00242-3","volume":"42","author":"H Kato","year":"2003","unstructured":"Kato, H., et al. (2003). Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung. Lung Cancer, 42(1), 103\u2013111.","journal-title":"Lung Cancer"},{"key":"906_CR11","doi-asserted-by":"publisher","first-page":"686303","DOI":"10.3389\/fchem.2021.686303","volume":"9","author":"G Gunaydin","year":"2021","unstructured":"Gunaydin, G., Gedik, M. E., & Ayan, S. (2021). Photodynamic Therapy for the Treatment and Diagnosis of Cancer-A Review of the Current Clinical Status. Frontiers In Chemistry, 9, 686303.","journal-title":"Frontiers In Chemistry"},{"issue":"9","key":"906_CR12","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1007\/s10495-010-0479-7","volume":"15","author":"AD Garg","year":"2010","unstructured":"Garg, A. D., et al. (2010). Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity. Apoptosis, 15(9), 1050\u20131071.","journal-title":"Apoptosis"},{"issue":"1","key":"906_CR13","first-page":"53","volume":"1805","author":"AD Garg","year":"2010","unstructured":"Garg, A. D., et al. (2010). Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation. Biochimica Et Biophysica Acta, 1805(1), 53\u201371.","journal-title":"Biochimica Et Biophysica Acta"},{"issue":"4","key":"906_CR14","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1042\/BJ20150942","volume":"473","author":"H Abrahamse","year":"2016","unstructured":"Abrahamse, H., & Hamblin, M. R. (2016). New photosensitizers for photodynamic therapy. The Biochemical Journal, 473(4), 347\u2013364.","journal-title":"The Biochemical Journal"},{"issue":"17","key":"906_CR15","doi-asserted-by":"publisher","first-page":"8588","DOI":"10.3390\/ijms26178588","volume":"26","author":"S Torna","year":"2025","unstructured":"Torna, S., Gkretsi, V., & Stylianou, A. (2025). Photodynamic Therapy and Tumor Microenvironment-Targeting Strategies: A Novel Synergy at the Frontier of Cancer Treatment. International Journal Of Molecular Sciences, 26(17), 8588.","journal-title":"Int J Mol Sci"},{"key":"906_CR16","doi-asserted-by":"publisher","first-page":"114100","DOI":"10.1016\/j.jconrel.2025.114100","volume":"386","author":"M Algarra","year":"2025","unstructured":"Algarra, M., et al. (2025). Recent developments in the use of carbon-based nanomaterials in cancer therapy. Journal Of Controlled Release : Official Journal Of The Controlled Release Society, 386, 114100.","journal-title":"Journal Of Controlled Release : Official Journal Of The Controlled Release Society"},{"issue":"77","key":"906_CR17","doi-asserted-by":"publisher","first-page":"14757","DOI":"10.1039\/D5CC02816G","volume":"61","author":"F Kradolfer","year":"2025","unstructured":"Kradolfer, F., Maake, C., & Spingler, B. (2025). Synergistic effects of combining phototherapeutics with traditional treatment modalities in oncology. Chem Commun Camb, 61(77), 14757\u201314772.","journal-title":"Chemical Communications (Cambridge)"},{"key":"906_CR18","unstructured":"Cho, H., Stephens, A. N., Marcuccio, S. M., Donner, C. D., Stockton, K. P., Skene, C., & Faber, J. (2022). Photodynamic Therapy and Diagnosis (Vol. 202211253712022112537A1). WO."},{"key":"906_CR19","doi-asserted-by":"publisher","first-page":"984268","DOI":"10.3389\/fchem.2022.984268","volume":"10","author":"H Abrahamse","year":"2022","unstructured":"Abrahamse, H., Hamblin, M. R., & George, S. (2022). Structure and functions of Aggregation-Induced Emission-Photosensitizers in anticancer and antimicrobial theranostics. Frontiers In Chemistry, 10, 984268.","journal-title":"Frontiers In Chemistry"},{"issue":"34","key":"906_CR20","doi-asserted-by":"publisher","first-page":"8349","DOI":"10.1039\/D4TB01175A","volume":"12","author":"S Zhang","year":"2024","unstructured":"Zhang, S., et al. (2024). Study of transient absorption spectroscopy of a D-pi-A structure aggregation-induced emission luminogen and its photodynamic therapy application. J Mater Chem B, 12(34), 8349\u20138356.","journal-title":"J Mater Chem B"},{"issue":"11","key":"906_CR21","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1039\/b605772a","volume":"5","author":"WW Chin","year":"2006","unstructured":"Chin, W. W., et al. (2006). The potential application of chlorin e6-polyvinylpyrrolidone formulation in photodynamic therapy. Photochemical & Photobiological Sciences, 5(11), 1031\u20131037.","journal-title":"Photochemical & Photobiological Sciences"},{"issue":"6","key":"906_CR22","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.3390\/ijms20061466","volume":"20","author":"L Moffitt","year":"2019","unstructured":"Moffitt, L. (2019). Therapeutic targeting of collective invasion in ovarian cancer. International Journal Of Molecular Sciences, 20(6), 1466.","journal-title":"International Journal Of Molecular Sciences"},{"key":"906_CR23","doi-asserted-by":"publisher","first-page":"932098","DOI":"10.3389\/fphar.2022.932098","volume":"13","author":"A Crous","year":"2022","unstructured":"Crous, A., & Abrahamse, H. (2022). Photodynamic therapy of lung cancer, where are we? Frontiers In Pharmacology, 13, 932098.","journal-title":"Frontiers In Pharmacology"},{"key":"906_CR24","doi-asserted-by":"publisher","first-page":"1024576","DOI":"10.3389\/fonc.2022.1024576","volume":"12","author":"D Bartusik-Aebisher","year":"2022","unstructured":"Bartusik-Aebisher, D., et al. (2022). Advancements in photodynamic therapy of esophageal cancer. Frontiers In Oncology, 12, 1024576.","journal-title":"Frontiers In Oncology"},{"key":"906_CR25","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.omto.2022.12.009","volume":"28","author":"M Sasaki","year":"2023","unstructured":"Sasaki, M., et al. (2023). Anti-tumor immunity enhancement by photodynamic therapy with talaporfin sodium and anti-programmed death 1 antibody. Molecular Therapy - Oncolytics, 28, 118\u2013131.","journal-title":"Molecular Therapy - Oncolytics"},{"key":"906_CR26","doi-asserted-by":"crossref","unstructured":"Maharjan, P. S., & Bhattarai, H. K. (2022). Singlet Oxygen, Photodynamic Therapy, and Mechanisms of Cancer Cell Death. J Oncol, 2022: 7211485.","DOI":"10.1155\/2022\/7211485"},{"issue":"23","key":"906_CR27","doi-asserted-by":"publisher","first-page":"16890","DOI":"10.3390\/ijms242316890","volume":"24","author":"M Przygoda","year":"2023","unstructured":"Przygoda, M. (2023). Cellular mechanisms of singlet oxygen in photodynamic therapy. International Journal Of Molecular Sciences, 24(23), 16890.","journal-title":"International Journal Of Molecular Sciences"},{"issue":"12","key":"906_CR28","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1093\/jnci\/90.12.889","volume":"90","author":"TJ Dougherty","year":"1998","unstructured":"Dougherty, T. J., et al. (1998). Photodynamic therapy. Journal Of The National Cancer Institute, 90(12), 889\u2013905.","journal-title":"Journal Of The National Cancer Institute"},{"issue":"8","key":"906_CR29","doi-asserted-by":"publisher","first-page":"e103126","DOI":"10.1371\/journal.pone.0103126","volume":"9","author":"S Ohashi","year":"2014","unstructured":"Ohashi, S., et al. (2014). Preclinical validation of talaporfin sodium-mediated photodynamic therapy for esophageal squamous cell carcinoma. PLoS One, 9(8), e103126.","journal-title":"PLoS One"},{"issue":"6","key":"906_CR30","doi-asserted-by":"publisher","first-page":"821","DOI":"10.2131\/jts.39.821","volume":"39","author":"Y Miki","year":"2014","unstructured":"Miki, Y., et al. (2014). Effect of talaporfin sodium-mediated photodynamic therapy on cell death modalities in human glioblastoma T98G cells. Journal Of Toxicological Sciences, 39(6), 821\u2013827.","journal-title":"Journal Of Toxicological Sciences"},{"issue":"6","key":"906_CR31","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1007\/s10103-015-1783-9","volume":"30","author":"Y Miki","year":"2015","unstructured":"Miki, Y., et al. (2015). Photodynamic therapy using talaporfin sodium induces concentration-dependent programmed necroptosis in human glioblastoma T98G cells. Lasers In Medical Science, 30(6), 1739\u20131745.","journal-title":"Lasers In Medical Science"},{"issue":"2","key":"906_CR32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1248\/bpb.b12-00567","volume":"36","author":"Y Miki","year":"2013","unstructured":"Miki, Y., et al. (2013). Photodynamic therapy in combination with talaporfin sodium induces mitochondrial apoptotic cell death accompanied with necrosis in glioma cells. Biological &\/And Pharmaceutical Bulletin, 36(2), 215\u2013221.","journal-title":"Biological &\/And Pharmaceutical Bulletin"},{"issue":"13","key":"906_CR33","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1039\/D0SC00785D","volume":"11","author":"Z Zhuang","year":"2020","unstructured":"Zhuang, Z., et al. (2020). Type I photosensitizers based on phosphindole oxide for photodynamic therapy: apoptosis and autophagy induced by endoplasmic reticulum stress. Chemical Science, 11(13), 3405\u20133417.","journal-title":"Chemical Science"},{"issue":"46","key":"906_CR34","doi-asserted-by":"publisher","first-page":"81591","DOI":"10.18632\/oncotarget.20189","volume":"8","author":"J Kou","year":"2017","unstructured":"Kou, J., Dou, D., & Yang, L. (2017). Porphyrin photosensitizers in photodynamic therapy and its applications. Oncotarget, 8(46), 81591\u201381603.","journal-title":"Oncotarget"},{"issue":"9","key":"906_CR35","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s00432-014-1717-0","volume":"140","author":"LJ Zhang","year":"2014","unstructured":"Zhang, L. J., et al. (2014). Photosensitizing effectiveness of a novel chlorin-based photosensitizer for photodynamic therapy in vitro and in vivo. Journal Of Cancer Research And Clinical Oncology, 140(9), 1527\u20131536.","journal-title":"Journal Of Cancer Research And Clinical Oncology"},{"issue":"2","key":"906_CR36","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1189\/jlb.0111006","volume":"90","author":"CW Chen","year":"2011","unstructured":"Chen, C. W., et al. (2011). Nuclear phospholipid scramblase 1 prolongs the mitotic expansion of granulocyte precursors during G-CSF-induced granulopoiesis. Journal Of Leukocyte Biology, 90(2), 221\u2013233.","journal-title":"Journal Of Leukocyte Biology"},{"issue":"6","key":"906_CR37","doi-asserted-by":"publisher","first-page":"821","DOI":"10.2131\/jts.39.821","volume":"39","author":"Y Miki","year":"2014","unstructured":"Miki, Y., et al. (2014). Effect of talaporfin sodium-mediated photodynamic therapy on cell death modalities in human glioblastoma T98G cells. The Journal of Toxicological Sciences, 39(6), 821\u2013827.","journal-title":"The Journal of Toxicological Sciences"},{"issue":"9","key":"906_CR38","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.3390\/pharmaceutics15092257","volume":"15","author":"TE Kim","year":"2023","unstructured":"Kim, T. E., & Chang, J. E. (2023). Recent studies in photodynamic therapy for cancer treatment: From basic research to clinical trials. Pharmaceutics, 15(9), 2257.","journal-title":"Pharmaceutics"},{"issue":"5","key":"906_CR39","doi-asserted-by":"publisher","first-page":"11417","DOI":"10.3390\/s150511417","volume":"15","author":"K Awasthi","year":"2015","unstructured":"Awasthi, K., et al. (2015). Fluorescence characteristics and lifetime images of photosensitizers of talaporfin sodium and sodium pheophorbide a in normal and cancer cells. Sensors (Basel), 15(5), 11417\u201311430.","journal-title":"Sensors (Basel)"},{"key":"906_CR40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40824-018-0140-z","volume":"22","author":"R Baskaran","year":"2018","unstructured":"Baskaran, R., Lee, J., & Yang, S. G. (2018). Clinical development of photodynamic agents and therapeutic applications. Biomater Res, 22, 25.","journal-title":"Biomater Res"},{"issue":"1","key":"906_CR41","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1038\/s41467-020-15591-4","volume":"11","author":"C Liu","year":"2020","unstructured":"Liu, C., et al. (2020). An open source and reduce expenditure ROS generation strategy for chemodynamic\/photodynamic synergistic therapy. Nature Communications, 11(1), 1735.","journal-title":"Nature Communications"},{"issue":"4","key":"906_CR42","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s12276-021-00599-7","volume":"53","author":"DL Sai","year":"2021","unstructured":"Sai, D. L., et al. (2021). Tailoring photosensitive ROS for advanced photodynamic therapy. Experimental & Molecular Medicine, 53(4), 495\u2013504.","journal-title":"Experimental & Molecular Medicine"},{"issue":"23","key":"906_CR43","doi-asserted-by":"publisher","first-page":"6597","DOI":"10.1039\/C6CS00271D","volume":"45","author":"Z Zhou","year":"2016","unstructured":"Zhou, Z., et al. (2016). Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy. Chemical Society reviews, 45(23), 6597\u20136626.","journal-title":"Chemical Society reviews"},{"issue":"1","key":"906_CR44","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/cam4.3592","volume":"10","author":"L Ming","year":"2021","unstructured":"Ming, L., et al. (2021). Enhancement of tumor lethality of ROS in photodynamic therapy. Cancer Medicine, 10(1), 257\u2013268.","journal-title":"Cancer Medicine"},{"issue":"1","key":"906_CR45","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1038\/s41467-022-29862-9","volume":"13","author":"J An","year":"2022","unstructured":"An, J., et al. (2022). An unexpected strategy to alleviate hypoxia limitation of photodynamic therapy by biotinylation of photosensitizers. Nature Communications, 13(1), 2225.","journal-title":"Nature Communications"},{"issue":"17","key":"906_CR46","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1016\/S0040-4020(98)00015-5","volume":"54","author":"ED Sternberg","year":"1998","unstructured":"Sternberg, E. D., Dolphin, D., & Br\u00fcckner, C. (1998). Porphyrin-based photosensitizers for use in photodynamic therapy. Tetrahedron, 54(17), 4151\u20134202.","journal-title":"Tetrahedron"},{"issue":"4","key":"906_CR47","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3390\/jcm10040841","volume":"10","author":"H Kataoka","year":"2021","unstructured":"Kataoka, H. (2021). Potential of photodynamic therapy based on sugar-conjugated photosensitizers. J Clin Med, 10(4), 841.","journal-title":"J Clin Med"},{"key":"906_CR48","doi-asserted-by":"publisher","first-page":"873245","DOI":"10.3389\/fchem.2022.873245","volume":"10","author":"M Laranjo","year":"2022","unstructured":"Laranjo, M. (2022). Ring-fused meso-tetraarylchlorins as auspicious PDT sensitizers: Synthesis, structural characterization, photophysics, and biological evaluation. Frontiers in Chemistry, 10, 873245.","journal-title":"Frontiers in Chemistry"},{"key":"906_CR49","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/jlac.19284660114","volume":"466","author":"H Fischer","year":"1928","unstructured":"Fischer, H., & Treibs, A. (1928). Chlorophyll. I. Etioporphyrins from plant- and blood-pigment porphyrins. Justus Liebigs Annalen der Chemie, 466, 188\u2013242.","journal-title":"Justus Liebigs Annalen der Chemie"},{"key":"906_CR50","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/jlac.19475570114","volume":"557","author":"M Strell","year":"1947","unstructured":"Strell, M., Iscimenler, E., & Chlorophyll (1947). CXXVIII. Partial esterification in the chlorin and porphyrin series. Justus Liebigs Annalen der Chemie, 557, 186\u2013192.","journal-title":"Justus Liebigs Annalen der Chemie"},{"issue":"8","key":"906_CR51","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1002\/cncr.11708","volume":"98","author":"RA Lustig","year":"2003","unstructured":"Lustig, R. A., et al. (2003). A multicenter Phase I safety study of intratumoral photoactivation of talaporfin sodium in patients with refractory solid tumors. Cancer, 98(8), 1767\u20131771.","journal-title":"Cancer"},{"issue":"5","key":"906_CR52","doi-asserted-by":"publisher","first-page":"11417","DOI":"10.3390\/s150511417","volume":"15","author":"K Awasthi","year":"2015","unstructured":"Awasthi, K., et al. (2015). Fluorescence characteristics and lifetime images of photosensitizers of talaporfin sodium and sodium pheophorbide a in normal and cancer cells. Sensors (Basel), 15(5), 11417\u201311430.","journal-title":"Sensors (Basel)"},{"issue":"2","key":"906_CR53","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.vascn.2010.10.004","volume":"63","author":"C Sanmart\u00edn-Su\u00e1rez","year":"2011","unstructured":"Sanmart\u00edn-Su\u00e1rez, C., et al. (2011). Antioxidant properties of dimethyl sulfoxide and its viability as a solvent in the evaluation of neuroprotective antioxidants. Journal Of Pharmacological And Toxicological Methods, 63(2), 209\u2013215.","journal-title":"Journal Of Pharmacological And Toxicological Methods"}],"container-title":["Photochemical & Photobiological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43630-026-00906-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43630-026-00906-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43630-026-00906-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:05:37Z","timestamp":1781517937000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43630-026-00906-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["906"],"URL":"https:\/\/doi.org\/10.1007\/s43630-026-00906-z","relation":{},"ISSN":["1474-905X","1474-9092"],"issn-type":[{"value":"1474-905X","type":"print"},{"value":"1474-9092","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Funding and equipment required to carry out this work were provided by Invion Ltd. Michael Cho is a founding board member and director of RMW Cho, which has a 4.73% shareholding in Invion Ltd. The authors have no other financial interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}